- Lobbying
- Lobbying by Tiber Creek Health Strategies, Inc. (On behalf of Genentech, Inc.)
Lobbying Relationship
Bills mentioned
S.934: FDA Reauthorization Act of 2017
Sponsor: Lamar Alexander (R-Tenn.)
S.2852: Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Sponsor: Richard M. Burr (R-N.C.)
S.2543: Prescription Drug Pricing Reduction Act of 2019
Sponsor: Charles E. Grassley (R-Iowa)
H.R.3: Elijah E. Cummings Lower Drug Costs Now Act
Sponsor: Frank Pallone (D-N.J.)
H.R.1865: Further Consolidated Appropriations Act, 2020
Sponsor: Bill Pascrell Jr. (D-N.J.)
H.R.6201: Families First Coronavirus Response Act
Sponsor: Nita M. Lowey (D-N.Y.)
S.3548: CARES Act
Sponsor: Mitch McConnell (R-Ky.)
H.R.6800: The Heroes Act
Sponsor: Nita M. Lowey (D-N.Y.)
H.R.133: Consolidated Appropriations Act, 2021
Sponsor: Henry Cuellar (D-Texas)
S.1435: Affordable Prescriptions for Patients Act of 2021
Sponsor: John Cornyn (R-Texas)
H.R.2873: Affordable Prescriptions for Patients Through Promoting Competition Act...
Sponsor: David Cicilline (D-R.I.)
H.R.5260: Reduced Costs and Continued Cures Act
Sponsor: Scott Peters (D-Calif.)
H.R.5376: Inflation Reduction Act of 2022
Sponsor: John Yarmuth (D-Ky.)
S.4446: Modernizing the Accelerated Approval Pathway Act of 2022
Sponsor: Susan Collins (R-Maine)
S.1264: SMART Prices Act
Sponsor: Amy Klobuchar (D-Minn.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Jonathon Jones | Chief of Staff, Senator Carper Chief of Staff, Senator Carper; Legislative Director, Senator Carper |
John Michael Gonzalez | Chief of Staff, Rep. Melissa Bean |
Lindsey Ledwin | Executive Asst./ Senior Scheduler for Sen. Snowe |
Sheila Murphy | Legislative Director, Rep. Richard Durbin Legislative Director, Senator Bob Kerrey Legislative Director, Senator Ben Nelson Legislative Director, Senator Tom Carper LD and Interim COS, Senator Amy Klobuchar Subcomm. on Fed. Financial Mgmnt Senior Foreign Policy Advisor, Senator Daschle |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. House of Representatives
U.S. Senate
U.S. House of Representatives
U.S. Senate
U.S. House of Representatives
U.S. Senate
U.S. House of Representatives
U.S. Senate
U.S. House of Representatives
U.S. Senate
U.S. House of Representatives
U.S. Senate
U.S. House of Representatives
U.S. Senate
U.S. House of Representatives
U.S. Senate
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
Commerce - Dept of (DOC)
U.S. House of Representatives
U.S. House of Representatives
U.S. Senate
Commerce - Dept of (DOC)
U.S. House of Representatives
U.S. House of Representatives
Commerce - Dept of (DOC)
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. Senate
Pharmacy
U.S. Senate
U.S. Senate
Medical
Pharmacy
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate